SCHEMBL21214775

SCHEMBL21214775

c1ccc(-c2ccc(N(c3ccc(-c4cccc5c(-c6ccccc6)cccc45)cc3)c3cccc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC14B O60729 3/20 0.35
CDC14A Q9UNH5 3/20 0.35
PLA2G2A P14555 4/20 0.35
PLA2G4A P47712 4/20 0.35
ALOX5 P09917 1/20 0.34
TNKS O95271 2/20 0.33
CRHR1 P34998 1/20 0.33
PLA2G10 O15496 1/20 0.33
MAOA P21397 2/20 0.33
CYP3A4 P08684 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
NPC1 O15118 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
TP53 P04637 1/20 0.33
ABCB1 P08183 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21206181 0.97 CDC14B (0.38) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL22523515 0.96 BACE1 (0.35) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL22523514 0.96 BACE1 (0.35) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL17721407 0.96 BACE1 (0.35) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL24370072 0.96 CDC14B (0.36) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL25517317 0.95 PLA2G2A (0.34) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL24370052 0.94 CDC14B (0.35) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL24370019 0.94 CDC14B (0.35) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL17709537 0.94 ALOX5 (0.34) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL14295628 0.94 PLA2G2A (0.38) CDC14BCDC14APLA2G2APLA2G4ATNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11805697-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-31 US disclosed
US-11805697-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-10-31 US disclosed
US-20230055036-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2023-02-23 US disclosed
US-20190237676-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055036-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC18A2, SLC18A1, MAOA CDC14B 4465/4885CDC14A 4439/4885PLA2G2A 4061/4885
US-11805697-B2 Organic electroluminescence device and monoamine compound for organic electroluminescence device SLC18A2, SLC18A1, MAOA CDC14B 4465/4885CDC14A 4439/4885PLA2G2A 4061/4885
US-20190237676-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC18A2, SLC18A1, MAOA CDC14B 4465/4885CDC14A 4439/4885PLA2G2A 4061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.